Charles Schwab
ARRY

Charles Schwab’s Array Biopharma Inc ARRY Stock Holding History

Charles Schwab’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,379,207
Closed -$63.9M – 3238
2019
Q2 		$63.9M Buy
1,379,207
+14,396
+1% +$404K 0.04% 457
2019
Q1 		$33.3M Buy
1,364,811
+150,968
+12% +$3.14M 0.02% 790
2018
Q4 		$17.3M Sell
1,213,843
-31,829
-3% -$483K 0.01% 1081
2018
Q3 		$18.9M Buy
1,245,672
+87,392
+8% +$1.34M 0.01% 1179
2018
Q2 		$19.4M Buy
1,158,280
+103,430
+10% +$1.65M 0.01% 1103
2018
Q1 		$17.2M Buy
1,054,850
+92,956
+10% +$1.49M 0.01% 1109
2017
Q4 		$12.3M Buy
961,894
+173,892
+22% +$1.98M 0.01% 1335
2017
Q3 		$9.69M Buy
788,002
+56,815
+8% +$528K 0.01% 1458
2017
Q2 		$6.12M Buy
731,187
+6,318
+0.9% +$51.7K 0.01% 1688
2017
Q1 		$6.48M Buy
724,869
+51,576
+8% +$549K 0.01% 1601
2016
Q4 		$5.92M Buy
673,293
+175,682
+35% +$1.29M 0.01% 1627
2016
Q3 		$3.36M Sell
497,611
-17,706
-3% -$68.5K ﹤0.01% 1877
2016
Q2 		$1.83M Buy
515,317
+8,448
+2% +$27.5K ﹤0.01% 2113
2016
Q1 		$1.5M Buy
506,869
+9,624
+2% +$28.8K ﹤0.01% 2185
2015
Q4 		$2.1M Sell
497,245
-12,192
-2% -$55.6K ﹤0.01% 2051
2015
Q3 		$2.32M Buy
509,437
+52,306
+11% +$310K ﹤0.01% 1979
2015
Q2 		$3.3M Buy
457,131
+12,081
+3% +$89.2K ﹤0.01% 1816
2015
Q1 		$3.28M Buy
445,050
+98,853
+29% +$704K ﹤0.01% 1775
2014
Q4 		$1.64M Buy
346,197
+7,564
+2% +$29.9K ﹤0.01% 2123
2014
Q3 		$1.21M Sell
338,633
-8,486
-2% -$33.5K ﹤0.01% 2218
2014
Q2 		$1.58M Buy
347,119
+36,260
+12% +$150K ﹤0.01% 2101
2014
Q1 		$1.46M Buy
310,859
+30,625
+11% +$154K ﹤0.01% 2097
2013
Q4 		$1.4M Buy
280,234
+8,862
+3% +$48.2K ﹤0.01% 2105
2013
Q3 		$1.75M Sell
271,372
-1,078
-0.4% -$6.4K ﹤0.01% 1928
2013
Q2 		$1.29M Buy
+272,450
New +$1.47M ﹤0.01% 2012

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Charles Schwab's ARRY Position: Q3 2019 in Review

Charles Schwab sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,379,207 shares — an estimated $63.9M sold.

Charles Schwab first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $63.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Charles Schwab reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Charles Schwab sold 1,379,207 Array Biopharma Inc shares in Q3 2019, an estimated $63.9M.
  • Charles Schwab first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Charles Schwab's Array Biopharma Inc position peaked at $63.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Charles Schwab's 13F filing for Q3 2019, filed 8 Nov 2019.